The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia

被引：3
|
作者：
Ding, Zhi-Chun [1 ]
机构：
[1] Augusta Univ, Georgia Canc Ctr, Canc Immunol Immunotherapy & Tolerance Program, 1120 15th St,CN4144B, Augusta, GA 30912 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2018年 / 6卷 / 11期
关键词：
CANCER REGRESSION; METASTATIC MELANOMA; IMMUNOTHERAPY; LYMPHOCYTES; THERAPY; GENE; CYCLOPHOSPHAMIDE; PERSISTENCE; EXPRESSION; RESPONSES;
D O I：
10.21037/atm.2018.05.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [1] Chimeric Antigen Receptor T Cells for B-Cell Acute Lymphoblastic Leukemia
    Ceppi, Francesco
    Gardner, Rebecca A.
    CANCER JOURNAL, 2019, 25 (03): : 191 - 198
  • [2] Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
    Locatelli, Franco
    del Bufalo, Francesca
    Quintarelli, Concetta
    HAEMATOLOGICA, 2024, 109 (06) : 1689 - 1699
  • [3] Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
    Tomuleasa, Ciprian
    Fuji, Shigeo
    Berce, Cristian
    Onaciu, Anca
    Chira, Sergiu
    Petrushev, Bobe
    Micu, Wilhelm-Thomas
    Moisoiu, Vlad
    Osan, Ciprian
    Constantinescu, Catalin
    Pasca, Sergiu
    Jurj, Ancuta
    Pop, Laura
    Berindan-Neagoe, Ioana
    Dima, Delia
    Kitano, Shigehisa
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] ANTI-CD123 CHIMERIC ANTIGEN RECEPTOR REDIRECTED T CELLS FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Ruella, M.
    Shestova, O.
    Kenderian, S.
    Barrett, D.
    Grupp, S.
    Scholler, J.
    Lacey, S.
    Kalos, M.
    June, C. H.
    Gill, S.
    CYTOTHERAPY, 2014, 16 (04) : S8 - S8
  • [5] Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia
    Grover, Punita
    Veilleux, Olivier
    Tian, Lu
    Sun, Ryan
    Previtera, Melissa
    Curran, Emily
    Muffly, Lori
    BLOOD ADVANCES, 2022, 6 (05) : 1608 - 1618
  • [6] Exudative Retinal Detachment Following Chimeric Antigen Receptor T-Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
    Khanna, Saira
    Mackin, Anna G.
    Dao, David T.
    Komati, Rahul
    Morocco, Perry C.
    LaBelle, James L.
    Shah, Hassan A.
    Blair, Michael P.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2022, 53 (02): : 113 - 115
  • [7] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory Pediatric B-Cell Acute Lymphoblastic Leukemia
    Lin, John K.
    Lerman, Benjamin J.
    Barnes, James I.
    Boursiquot, Brian C.
    Tan, Yuan Jin
    Robinson, Alex Q. L.
    Davis, Kara L.
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (32) : 3192 - +
  • [8] Chimeric antigen receptor (CAR) T-cells in acute B-cell leukemia
    Hudecek M.
    best practice onkologie, 2019, 14 (1-2) : 20 - 25
  • [9] Chimeric antigen receptor T cells for acute lymphoblastic leukemia
    Frey, Noelle V.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S24 - S27
  • [10] Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemia
    Zhao Xiangyu
    Wu Haotian
    Cheng Yifei
    Xu Zhengli
    Chen Yuhong
    Chang Yingjun
    Wang Yu
    Zhang Xiaohui
    Xu Lanping
    Huang Xiaojun
    中华医学杂志英文版, 2023, 136 (16)
12345